Olfaction and Parkinson's syndromes: its role in differential diagnosis

Purpose of reviewMarked olfactory dysfunction (hyposmia) is a frequent and early abnormality in Parkinson's disease. We review recent advances related to its cause and its clinical relevance with respect to the differential diagnosis of Parkinsonian syndromes. Recent findingsMarked olfactory dysfunction occurs in Parkinson's disease and dementia with Lewy bodies but is not found in progressive supranuclear palsy and corticobasal degeneration. In multiple system atrophy, the deficit is mild and indistinguishable from cerebellar syndromes of other aetiologies, including the spino-cerebllar ataxias. This is in keeping with evidence of cerebellar involvement in olfactory processing, which may also help to explain recent findings of mild olfactory dysfunction in essential tremor. Smell testing remains, however, a clinically relevant tool in the differential diagnosis of indeterminate tremors. Intact olfaction has also been reported recently in Parkin disease (PARK 2) and vascular Parkinsonism. The relevance of sniffing ability to olfaction and a possible role of increased tyrosine hydroxylase and dopamine in parts of the olfactory bulb are issues of current interest with respect to pathophysiology. The early or ‘pre-clinical’ detection of Parkinson's disease is increasingly recognized as an area in which olfactory testing may be of value. SummaryResearch findings have confirmed a role for olfactory testing in the differential diagnosis of movement disorders, and suggest that this approach is currently underused in clinical practice. Validated test batteries are now available that may prove to be of practical use in the differential diagnosis of Parkinsonian syndromes and indeterminate tremors.

[1]  Thomas Hummel,et al.  Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT , 2004, Movement disorders : official journal of the Movement Disorder Society.

[2]  T. Hummel,et al.  'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. , 1997, Chemical senses.

[3]  C. Hawkes,et al.  Olfactory Evoked Responses and Identification Tests in Neurological Disease , 1998, Annals of the New York Academy of Sciences.

[4]  J. D. E. Gabrieli,et al.  Sniffing and smelling: separate subsystems in the human olfactory cortex , 1998, Nature.

[5]  A. Lees,et al.  Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  R. Doty,et al.  Development of the 12‐Item Cross‐Cultural Smell Identification Test(CC‐SIT) , 1996, The Laryngoscope.

[7]  G. Halliday,et al.  Olfactory deficits and sleep disturbances in Parkinson’s disease: a case–control survey , 2003, Journal of neurology, neurosurgery, and psychiatry.

[8]  P. Adeleine,et al.  Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease. , 2003, Chemical senses.

[9]  A. Johnson,et al.  Olfactory function in patients with Parkinson's disease. , 1975, Journal of chronic diseases.

[10]  N. Quinn,et al.  Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease , 2004, Neurology.

[11]  J D Gabrieli,et al.  An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Jankovic,et al.  Clinical correlates of vascular parkinsonism. , 1999, Archives of neurology.

[13]  E. Louis,et al.  Olfactory dysfunction in essential tremor , 2002, Neurology.

[14]  K. Lyons,et al.  Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery , 2000, Movement disorders : official journal of the Movement Disorder Society.

[15]  R. Birgander,et al.  Is p53 polymorphism maintained by natural selection? , 1994, Human heredity.

[16]  A. Smith,et al.  Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology , 2001, Journal of neurology, neurosurgery, and psychiatry.

[17]  W. Ondo,et al.  Olfaction testing in patients with tremor‐dominant Parkinson's disease: Is this a distinct condition? , 2005, Movement disorders : official journal of the Movement Disorder Society.

[18]  H. Berendse,et al.  Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell , 2001, Annals of neurology.

[19]  V. Fung,et al.  Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. , 2003, Archives of neurology.

[20]  H. Reichmann,et al.  Olfactory function in Parkinsonian syndromes , 2002, Journal of Clinical Neuroscience.

[21]  A. Lees,et al.  Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation , 2001 .

[22]  S. Daniel,et al.  Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology , 1992, The Lancet.

[23]  P. Liberini,et al.  Assessing olfaction in the Italian population: methodology and clinical application , 1999, The Italian Journal of Neurological Sciences.

[24]  H. Uylings,et al.  A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[25]  D. Vodušek,et al.  Sphincter EMG and differential diagnosis of multiple system atrophy , 2001, Movement disorders : official journal of the Movement Disorder Society.

[26]  R. Pahwa,et al.  Olfactory function in essential tremor , 1992, Neurology.

[27]  C Adler,et al.  Olfactory function in Parkinson's disease subtypes , 1994, Neurology.

[28]  A. Lees,et al.  Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. , 2001, Movement disorders : official journal of the Movement Disorder Society.

[29]  C. Hawkes Olfaction in neurodegenerative disorder , 2003, Movement disorders : official journal of the Movement Disorder Society.

[30]  Jan Booij,et al.  The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.

[31]  R. Doty,et al.  Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[32]  P. Duchamp-Viret,et al.  Dopaminergic modulation of mitral cell activity in the frog olfactory bulb: a combined radioligand binding–electrophysiological study , 1997, Neuroscience.

[33]  I Litvan,et al.  Progressive supranuclear palsy and corticobasal degeneration. , 2011 .

[34]  P. Thompson,et al.  A positron emission tomography study of cerebral activation associated with essential and writing tremor. , 1995, Archives of neurology.

[35]  E. Louis,et al.  Olfaction in essential tremor patients with and without isolated rest tremor , 2003, Movement disorders : official journal of the Movement Disorder Society.

[36]  D. Brooks,et al.  Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome , 2000, Journal of neurology, neurosurgery, and psychiatry.

[37]  P. Lantos,et al.  Olfactory bulb in multiple system atrophy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[38]  T. Yen,et al.  Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2 , 2002, Movement disorders : official journal of the Movement Disorder Society.

[39]  E. Montgomery,et al.  Abnormal performance on the PD test battery by asymptomatic first-degree relatives , 1999, Neurology.

[40]  M. A. van 't Hof,et al.  MRI in patients with suspected vascular parkinsonism , 1995, Neurology.

[41]  R. Doty,et al.  Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease , 1993, Neurology.

[42]  P. Moberg,et al.  Odor identification in Huntington's disease patients and asymptomatic gene carriers. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[43]  J M Farmer,et al.  Olfactory dysfunction in degenerative ataxias , 2003, Journal of neurology, neurosurgery, and psychiatry.

[44]  M. C. Newman,et al.  Early detection of probable idiopathic Parkinson's disease: I. development of a diagnostic test battery , 2000, Movement disorders : official journal of the Movement Disorder Society.

[45]  D. Malaspina,et al.  A brief smell identification test discriminates between deficit and non-deficit schizophrenia , 2003, Psychiatry Research.

[46]  D. Dickson,et al.  Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ɛ4 , 2003 .

[47]  B. Shephard,et al.  Olfactory function in atypical parkinsonian syndromes , 1995, Acta neurologica Scandinavica.

[48]  R. Doty,et al.  Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function , 1984, Physiology & Behavior.

[49]  R. Doty,et al.  Olfactory dysfunction in parkinsonism , 1988, Neurology.

[50]  Gary H. Glover,et al.  Odorant-Induced and Sniff-Induced Activation in the Cerebellum of the Human , 1998, The Journal of Neuroscience.

[51]  R. Camicioli,et al.  Discriminating mild parkinsonism: Methods for epidemiological research , 2001, Movement disorders : official journal of the Movement Disorder Society.

[52]  M. Oechsner,et al.  Dopaminergic response in Parkinsonian phenotype of Machado‐Joseph disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[53]  H. Reichmann,et al.  Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients , 2002, Journal of Neural Transmission.

[54]  H. Berendse,et al.  Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis , 2001, Movement disorders : official journal of the Movement Disorder Society.

[55]  K. Bhatia,et al.  [123I]‐FP‐CIT‐SPECT demonstrates dopaminergic deficit in orthostatic tremor , 2003, Annals of neurology.

[56]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[57]  K. Leenders Significance of non‐presynaptic SPECT tracer methods in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[58]  P. Bentham,et al.  Olfactory identification is impaired in clinic‐based patients with vascular dementia and senile dementia of Alzheimer type , 2001, International journal of geriatric psychiatry.

[59]  D. Dickson,et al.  Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. , 2003, Neuropathology and applied neurobiology.

[60]  Andrew J Lees,et al.  Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis , 2004, Movement disorders : official journal of the Movement Disorder Society.

[61]  T. Hummel,et al.  Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease , 1997, Neurology.

[62]  Thomas Hummel,et al.  Olfactory dysfunction in cerebellar ataxia and multiple system atrophy , 2003, Journal of Neurology.

[63]  J. Nutt,et al.  SCA2 may present as levodopa‐responsive parkinsonism , 2003, Movement disorders : official journal of the Movement Disorder Society.

[64]  R. Huws,et al.  Olfactory acuity in the positive and negative syndromes of schizophrenia , 1991, Biological Psychiatry.

[65]  J. Vincent,et al.  Dopamine depresses synaptic inputs into the olfactory bulb. , 1999, Journal of neurophysiology.

[66]  G. Halliday,et al.  Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. , 2002, Brain : a journal of neurology.

[67]  B. Boeve,et al.  Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. , 2000, Brain : a journal of neurology.

[68]  Fractionation of visuoperceptual dysfunction in Parkinson's disease , 1995, Journal of the Neurological Sciences.

[69]  W. Ondo,et al.  Flumazenil, a GABA antagonist, may improve features of Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[70]  J. Noth,et al.  Evidence for a non-orthostatic origin of orthostatic tremor , 1999, Journal of neurology, neurosurgery, and psychiatry.

[71]  R. Doty,et al.  Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[72]  R. Stern,et al.  Odor Identification Deficits in Diffuse Lewy Body Disease , 2003, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[73]  P. Liberini,et al.  Olfaction in Parkinson’s disease: methods of assessment and clinical relevance , 2000, Journal of Neurology.

[74]  I. Richard,et al.  Parkinson's disease and dementia with Lewy bodies: One disease or two? , 2002, Movement disorders : official journal of the Movement Disorder Society.

[75]  A. Lang,et al.  Olfactory dysfunction in familial parkinsonism , 1997, Neurology.

[76]  Jane S. Paulsen,et al.  Sensory- and memory-mediated olfactory dysfunction in Huntington's disease , 1995, Journal of the International Neuropsychological Society.

[77]  S. Daniel,et al.  The anterior olfactory nucleus in Parkinson's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.

[78]  D. Woitalla,et al.  3-OMD and homocysteine plasma levels in parkinsonian patients , 2002, Journal of Neural Transmission.